Application 076688

Type
ANDA
Sponsor
MYLAN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEBENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDETABLET;ORAL5MG;6.25MGNoNo
002BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEBENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDETABLET;ORAL10MG;12.5MGNoNo
003BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEBENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDETABLET;ORAL20MG;12.5MGNoNo
004BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEBENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDETABLET;ORAL20MG;25MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0378-4725Benazepril Hydrochloride and Hydrochlorothiazidebenazepril hydrochloride and hydrochlorothiazideMylan Pharmaceuticals Inc.ANDACurrent
0378-4725Benazepril Hydrochloride and Hydrochlorothiazidebenazepril hydrochloride and hydrochlorothiazideMylan Pharmaceuticals Inc.ANDACurrent
0378-4735Benazepril Hydrochloride and Hydrochlorothiazidebenazepril hydrochloride and hydrochlorothiazideMylan Pharmaceuticals Inc.ANDACurrent
0378-4735Benazepril Hydrochloride and Hydrochlorothiazidebenazepril hydrochloride and hydrochlorothiazideMylan Pharmaceuticals Inc.ANDACurrent
0378-4745Benazepril Hydrochloride and Hydrochlorothiazidebenazepril hydrochloride and hydrochlorothiazideMylan Pharmaceuticals Inc.ANDACurrent
0378-4745Benazepril Hydrochloride and Hydrochlorothiazidebenazepril hydrochloride and hydrochlorothiazideMylan Pharmaceuticals Inc.ANDACurrent
0378-4775Benazepril Hydrochloride and Hydrochlorothiazidebenazepril hydrochloride and hydrochlorothiazideMylan Pharmaceuticals Inc.ANDACurrent
0378-4775Benazepril Hydrochloride and Hydrochlorothiazidebenazepril hydrochloride and hydrochlorothiazideMylan Pharmaceuticals Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
8948ORIG2004-02-12